Buying an independent pharmacy: What lenders want to see

Working in a pharmacy may not give enough insight for a successful purchase. These tips might make the process smoother.

opinion
Simon Palmer

Plenty of pharmacists still want to own their own business. Some are long-serving managers who know the patients and the surgery next door better than anyone. Others are employee pharmacists who have watched a local owner approach retirement and wondered whether they could take it on. The ambition is there. What often goes wrong is the funding, usually for reasons that could have been spotted months earlier.

Very few pharmacy purchases fall over because a lender dislikes community pharmacy. Most stall because the deal reaches a credit team with gaps in the story.

The NHS contract is the asset

When someone buys an independent pharmacy, most of the price is usually goodwill rather than fittings or stock. That goodwill rests largely on the NHS contract and the dispensing income it brings. Lenders who know the sector are comfortable with this, but they want to understand it properly.

Expect questions about monthly item volumes over the last couple of years, the trend in those volumes, and how income splits between dispensing, services and retail. A lender will also ask where the prescriptions come from. A pharmacy that relies heavily on one GP surgery is exposed if that surgery relocates, merges or changes how it works, and a buyer should look at that risk before a lender does.

Margins are harder to read than turnover

Turnover can look reassuring while profit tells a different story. Reimbursement prices move, medicine shortages squeeze purchasing margins, and staff costs have risen for almost every owner. Lenders know this, so they focus on what is left after the wholesaler, the wage bill and the rent have been paid.

Ask the seller for management accounts as well as filed accounts, and for an honest explanation of anything unusual. A one-off boost or a dip caused by a long staff absence is easy to explain early and awkward to explain once a lender has found it. If the seller has been taking a low salary or covering shifts unpaid, show the true cost of running the business, because a lender will.

Services income needs evidence

Clinical services matter to many pharmacies, and lenders generally see these as positive. They want to see that services income is recorded clearly, has been earned consistently, and does not depend on a pharmacist who is leaving with the seller. If a buyer plans to grow services, a short, realistic plan setting out who will deliver them and when beats a hopeful line in a forecast.

The premises matter more than people expect

A pharmacy is tied to its location, so the property side gets close attention. With leased premises, lenders look at how long is left on the lease, whether it can be assigned to the buyer, and whether it runs comfortably beyond the loan term. A short lease with no clear right to renew can hold up an otherwise sound purchase. If the freehold is included, a valuation will be needed, and that takes time.

Regulatory steps run alongside the funding

A change of ownership involves applications to the NHS and to the regulator, and their timing affects when money can be released. Lenders will usually want to see those applications under way. Leaving them until the funding is approved is one of the most common causes of delay.

What a buyer can do now

The strongest applications share a few features. The buyer has spoken to a funding specialist before agreeing heads of terms, so the price and payment structure reflect what can realistically be borrowed. They know their own contribution, whether savings, property equity or family support, and they understand that personal guarantees are often part of the conversation. They can explain the accounts in their own words.

They have also planned the first year, including wholesaler accounts, stock at handover, staffing and the cash needed before NHS payments arrive. A buyer who borrows exactly enough to complete, with nothing left for working capital, can find the first few months very uncomfortable.

Sellers sometimes agree to defer part of the price, which can make a deal easier to fund if it is structured sensibly. Raise it early, because lenders will want to know how deferred payments sit alongside their own.

Independent ownership is still achievable

None of this should put anyone off buying a pharmacy. Lenders continue to fund pharmacy purchases, and a well-prepared buyer with a clear story often has more options than expected. The key is to treat funding as part of the deal from the start, not a formality once the price is agreed.

Simon Palmer is director of Smart Funding Solutions.

Latest from Opinion

More from Analysis